Premium
The use of risperidone, an atypical neuroleptic, in lewy body disease
Author(s) -
Lee Heidi,
Cooney John M.,
Lawlor Brian A.
Publication year - 1994
Publication title -
international journal of geriatric psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 129
eISSN - 1099-1166
pISSN - 0885-6230
DOI - 10.1002/gps.930090511
Subject(s) - risperidone , lewy body , dementia with lewy bodies , dementia , psychiatry , senile dementia , medicine , extrapyramidal symptoms , parkinsonism , disease , psychology , degenerative disease , pediatrics , schizophrenia (object oriented programming) , antipsychotic
A case of senile dementia of Lewy body type (SDLBT) who developed severe and incapacitating extrapyramidal side‐effects (EPSE) following treatment with typical neuroleptics, but responded to and tolerated the new atypical neuroleptic risperidone, is described. The potential benefits of atypical neuroleptics for elderly dementia patients with concurrent psychotic and behavioural symptoms are discussed.